Physical medicine and rehabilitation deals in function. The interventions — power wheelchairs, prosthetics, orthotics, spasticity treatment, inpatient rehabilitation — are justified by what a patient can and cannot do. And prior authorization in PM&R requires proving exactly that, in a specific format, to payers who have set their own definitions of what counts as sufficient functional limitation.
The documentation is inherently subjective and inherently complex. That makes PM&R’s PA burden different in kind from specialties where the justification is a lab value or a trial failure. Functional documentation doesn’t reduce to a number.
The numbers in PM&R
PM&R-specific PA research is sparse, but the AMA’s 2024 Prior Authorization Physician Survey captures the cross-specialty burden — and the adverse-event signal maps clearly to PM&R’s patient population:
- 29% of physicians report PA led to a serious adverse event.
- 82% say PA can lead patients to abandon treatment.
- 93% say PA delays patient care.
- 39 authorizations per physician per week, ~13 hours lost to them (AMA 2024).
In PM&R, a serious adverse event from a PA delay can be a patient with progressive spasticity waiting months for Botox authorization, or a patient with a functional limitation living without the power wheelchair the physician determined they needed.
Why PM&R is different
- DME PA is among the most documentation-intensive in medicine. Medicare’s Local Coverage Determinations (LCDs) for power mobility devices require a face-to-face examination, a mobility assessment, a home environment evaluation, and a physician attestation of medical necessity — all in a specific format. Commercial payers often mirror these requirements. Each component must be present; a missing element triggers a denial or a Request for Additional Documentation.
- Botox for spasticity requires functional evidence. OnabotulinumtoxinA authorization for post-stroke, TBI, MS, or CP-related spasticity requires documentation of the neurological diagnosis, impairment severity, prior treatment failure (typically oral antispasmodics), and functional goals. The dosing limits and documentation requirements vary by payer and by injection site.
- Inpatient rehab facility (IRF) admission criteria. IRF admissions require prior authorization demonstrating the patient meets the 3-hour rule, the qualifying diagnosis criteria, and the expectation of functional improvement. A PA denial at the point of admission discharge routing can leave a patient in an acute hospital bed rather than moving to appropriate rehab level of care.
- Prosthetic and orthotic tiering. Payers tier prosthetics and orthotics by functional classification (K-levels for lower limb prosthetics), and authorization for higher-tier devices requires documented functional capacity that matches the device. A patient who could use a more functional prosthetic but is authorized only for a lower tier is limited by payer classification, not clinical judgment.
What it costs
The clinical cost in PM&R is functional limitation that persists beyond what clinical intervention would require. A patient in a manual wheelchair who needs a power wheelchair isn’t just inconvenienced — they’re limited in independence, mobility, and quality of life by an authorization that hasn’t cleared. A stroke survivor with untreated spasticity may develop contractures during the months a Botox authorization takes to resolve. The operational cost is documentation-intensive: assembling functional assessments, examination records, and prior treatment histories at roughly $10.81 per manually processed authorization (CAQH 2023) — across a patient population that generates complex, multi-device PA requirements.
How to cut the wait
PM&R authorization documentation is functional and clinical — examination records, assessment scores, prior treatment history, and device justification. Artificer Health:
- Assembles DME documentation — face-to-face examination records, mobility assessments, and the device-specific documentation Medicare’s LCDs and commercial payer criteria require.
- Builds the Botox spasticity record — neurological diagnosis, functional impairment, prior antispasmodic history, and the dosing/site documentation each payer requires.
- Manages IRF and rehab admission PA — clinical criteria documentation and the qualifying-diagnosis evidence that admission reviewers need to approve the level-of-care transition.
For a patient whose function depends on getting the right device or treatment authorized, weeks matter. First-pass approvals in hours — not weeks of documentation requests — are what keep functional outcomes on track.
Sources: AMA 2024 Prior Authorization Physician Survey (n=1,000); CMS Local Coverage Determinations (LCDs) for power mobility devices and lower-limb prosthetics; payer medical policies for onabotulinumtoxinA in spasticity; CAQH 2023 Index.